Lincoln Community Home Health | |
111 6th Street, Hugo, Colorado 80821 | |
(719) 743-2797 | |
Name | Lincoln Community Home Health |
---|---|
Location | 111 6th Street, Hugo, Colorado |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 67277 |
Ownership Type | Voluntary Non-profit - Other |
Service Area Zip Codes | 80101, 80105, 80218, 80804, 80815, 80818, 80821, 80823, 80828, 80832, 80833, 80835, 80862 |
NPI Number | 1033122544 |
Organization Name | LINCOLN COMMUNITY HOSPITAL |
Doing Business As | LINCOLN COMMUNITY HOME HEALTH & HOSPICE |
Address | 111 6th St, Hugo, CO 80821 |
Phone Number | 719-743-2797 |
News Archive
As winter cold descends on the nation, people tend to hunker down for warmth, often in places where others are in close proximity. It's a recipe for spreading colds.
Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Status for its drug candidate, CF102, for the treatment of hepatocellular carcinoma.
An impaired ability to handle oxidative stress that arises from exposure to secondhand smoke and other environmental triggers may contribute to the development of asthma, according to results obtained from the Shanghai Women's Health Asthma and Allergy Study. The results of the study suggest regulating the body's antioxidant defense system may play an important role in asthma prevention.
› Verified 9 days ago
Quality Rating: |
News Archive
As winter cold descends on the nation, people tend to hunker down for warmth, often in places where others are in close proximity. It's a recipe for spreading colds.
Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Status for its drug candidate, CF102, for the treatment of hepatocellular carcinoma.
An impaired ability to handle oxidative stress that arises from exposure to secondhand smoke and other environmental triggers may contribute to the development of asthma, according to results obtained from the Shanghai Women's Health Asthma and Allergy Study. The results of the study suggest regulating the body's antioxidant defense system may play an important role in asthma prevention.
› Verified 9 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 92.4 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 68.2 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 98.5 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 79.5 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 76.6 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
As winter cold descends on the nation, people tend to hunker down for warmth, often in places where others are in close proximity. It's a recipe for spreading colds.
Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Status for its drug candidate, CF102, for the treatment of hepatocellular carcinoma.
An impaired ability to handle oxidative stress that arises from exposure to secondhand smoke and other environmental triggers may contribute to the development of asthma, according to results obtained from the Shanghai Women's Health Asthma and Allergy Study. The results of the study suggest regulating the body's antioxidant defense system may play an important role in asthma prevention.
› Verified 9 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 47.2 | 79.6 |
How often patients got better at getting in and out of bed | 42.3 | 81.1 |
How often patients got better at bathing | 58.4 | 82.3 |
How often patients’ breathing improved | 52.3 | 82.8 |
How often patients’ wounds improved or healed after an operation | - | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 47 | 75 |
How often home health patients had to be admitted to the hospital | 6.7 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 20.1 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 93.9 | 94 |
News Archive
As winter cold descends on the nation, people tend to hunker down for warmth, often in places where others are in close proximity. It's a recipe for spreading colds.
Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Status for its drug candidate, CF102, for the treatment of hepatocellular carcinoma.
An impaired ability to handle oxidative stress that arises from exposure to secondhand smoke and other environmental triggers may contribute to the development of asthma, according to results obtained from the Shanghai Women's Health Asthma and Allergy Study. The results of the study suggest regulating the body's antioxidant defense system may play an important role in asthma prevention.
› Verified 9 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | Not Available |
Health team communicated well with them | Not Available |
Health team discussed medicines, pain, and home safety | Not Available |
How patients rated overall care from agency | Not Available |
News Archive
As winter cold descends on the nation, people tend to hunker down for warmth, often in places where others are in close proximity. It's a recipe for spreading colds.
Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Status for its drug candidate, CF102, for the treatment of hepatocellular carcinoma.
An impaired ability to handle oxidative stress that arises from exposure to secondhand smoke and other environmental triggers may contribute to the development of asthma, according to results obtained from the Shanghai Women's Health Asthma and Allergy Study. The results of the study suggest regulating the body's antioxidant defense system may play an important role in asthma prevention.
› Verified 9 days ago
The patient survey data of Lincoln Community Home Health is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 98 | 88 |
Percent of patients who reported that their home health team communicated well with them | 99 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 69 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 98 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 74 | 78 |
News Archive
As winter cold descends on the nation, people tend to hunker down for warmth, often in places where others are in close proximity. It's a recipe for spreading colds.
Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Status for its drug candidate, CF102, for the treatment of hepatocellular carcinoma.
An impaired ability to handle oxidative stress that arises from exposure to secondhand smoke and other environmental triggers may contribute to the development of asthma, according to results obtained from the Shanghai Women's Health Asthma and Allergy Study. The results of the study suggest regulating the body's antioxidant defense system may play an important role in asthma prevention.
› Verified 9 days ago
Lincoln Community Home Health Location: 111 6th Street, Hugo, Colorado 80821 Ratings: Phone: (719) 743-2797 |